Corporate Score 25 Neutral

Guggenheim reiterates Forte Biosciences stock rating ahead of data

Apr 02, 2026 15:07 UTC

FORT

Short term

Guggenheim reiterates Forte Biosciences stock rating ahead of data.

Share this article

Impact

Sentiment

Neutral

Type

Corporate

Horizon

Short

Risk Level

Low

AI will analyze the impact on affected symbols and provide trading insights

Get AI-powered insights, advanced filtering, real-time alerts, and unlimited analysis.

Apr 04, 01:57

Apr 04, 01:48

Apr 04, 01:48

Apr 04, 01:39

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.